Trxade Group Inc. MEDS Archives - Page 5 of 9

MondayJul 13, 2020 12:07 pm

Trxade Group, Inc. (NASDAQ: MEDS) Telehealth App Incorporates New Educational Resources for Patients

Pharmaceutical and health care services company Trxade Group has added new tools to its Bonum Health telemedicine platform that will help patients better inform themselves about their medical needs and their provider’s prescription recommendations Trxade Group operates a B2B pharmaceutical network that supports independent, neighborhood-based healthcare businesses with up-to-the-minute information on drug pricing The company also assists patients on a B2C basis through its subsidiaries that include Bonum Health’s telemedicine platform and Delivmeds’ pharmaceutical delivery service Trxade Group’s development of remote-access medical care during the past two years has proven timely in the face of restrictions on gatherings imposed during…

ThursdayJul 09, 2020 3:05 pm

QualityStocksNewsBreaks – Trxade Group, Inc. (NASDAQ: MEDS) Achieves Exciting Capital Markets Milestone as It Hits the Russell Index

Trxade Group (NASDAQ: MEDS), an integrated drug and healthcare platform, was recently added to the Russell Microcap Index, which helps raise its profile among investors, furthering its reach to generate long-term shareholder value while limiting marketing expenses. A recent article quotes Trxade Chairman and CEO Suren Ajjarapu about the Russell listing, stating, “This marks an exciting capital markets milestone in the growth and trajectory of our company as we continue to execute upon our growth strategy and raise awareness about the Company throughout the investment community.” To view the full article, visit http://ibn.fm/iFvtu About Trxade Group, Inc. Headquartered in Tampa,…

ThursdayJul 09, 2020 11:20 am

Trxade Group, Inc. (NASDAQ: MEDS) Invigorates Investors with Affirmative Presentation

Uplists to NASDAQ Added as component of Russell MicroCap Index Grew revenues 94% in 2019 Added 3,200 pharmacies in 2019 Total pharmacies on marketplace now number 11,400 Investors in Trxade Group (NASDAQ: MEDS) have received significant positive news regarding revenues and expansion. Revenues are up, and so too are earnings, as the company’s pharmaceutical platform gains in popularity. On average, every day in 2019, some eight or nine new pharmacies signed up to use Trxade’s services. All this and more came out in a recent online presentation featuring CEO Suren Ajjarapu. The presentation covered various aspects of the company’s operations,…

ThursdayJul 02, 2020 2:24 pm

QualityStocksNewsBreaks – Trxade Group, Inc.’s (NASDAQ: MEDS) Bonum Health Names New President

Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform, recently announced the appointment of Ashton Maaraba as president of Trxade Group’s Bonum Health telemedicine practice. An article discussing the company reads, “Maaraba has over 20 years of experience in developing and directing strategic national sales, marketing and operating initiatives in ever-changing, dynamic environments, according to the company, and will work to help build long-term shareholder value by welcoming a growing number of patients under the Bonum Health Hub platform. . . . ‘Ashton is an intuitive leader with acute business acumen and expertise in channel development and…

WednesdayJun 24, 2020 11:07 am

Trxade Group, Inc. (NASDAQ: MEDS) Brings Taglich Brothers Onboard to Build Brand Reporting, Welcomes New Bonum Health President

Trxade Group Inc. is a growing B2B pharmaceutical network that provides solutions to small healthcare businesses, care providers and medical patients through growing optimization of remote-access health services Amid the sweep of the global COVID-19 pandemic, Trxade Group has continued to build its vision of enabling the health industry to operate transparently and effectively even as the importance of changing remote-access medicine models grows Trxade Group recently began receiving research report coverage from investment services firm Taglich Brothers, Inc. as part of ongoing brand-building efforts The company also recently announced that experienced healthcare market advisory professional Ashton Maaraba has been…

TuesdayJun 23, 2020 12:14 pm

QualityStocksNewsBreaks – Trxade Group, Inc. (NASDAQ: MEDS) Selected for Inclusion on the Russell Microcap Index

Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform, today announced that it has been selected to be added to the Russell Microcap Index at the conclusion of the 2020 Russell indexes annual reconstitution. According to a preliminary list of additions posted June 5, 2020, Trxade Group’s membership will be effective after the U.S. market opens on June 29, 2020. Russell Microcap Index membership, which remains in place for one year, ensures automatic inclusion in the appropriate growth and value style indexes. "We are pleased to be added to the Russell Microcap Index, raising Trxade Group's visibility…

MondayJun 22, 2020 12:18 pm

QualityStocksNewsBreaks – Trxade Group, Inc. (NASDAQ: MEDS) Building Parallel Network to Healthcare Chains Such as Walgreens or CVS

Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform, is building a parallel network to healthcare chains such as Walgreens or CVS by bringing together independent pharmacies across the country under its technology and by offering a promise of same-day delivery. The company, which was recently uplisted to Nasdaq, has been bringing together independent pharmacies under one umbrella through its web-based purchasing platform and is now present in all 50 states and rapidly adding 100-150 pharmacies every month. In an interview with AlphaStreet, Trxade CEO Suren Ajjarapu said the company’s focus is to empower independent pharmacies to…

FridayJun 19, 2020 10:18 am

QualityStocksNewsBreaks – Champignon Brands Inc.’s (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) Dr. McIntyre / CRTCE Published in Two Peer Reviewed Study Journals

Champignon Brands (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496), a human optimization sciences company with an emphasis on ketamine and psychedelic medicine, continues to highlight the scientific merit of its ketamine treatments for Major Depressive Disorder (“MDD”) while demonstrating rapid onset efficacy and safety of its treatment processes. To this accord, the Company today announced that its Chief Executive Officer, Dr. Roger McIntyre, and the Canadian Rapid Treatment Centre of Excellence (the “CRTCE”) have been recently published in two peer reviewed study journals (the “Peer Reviewed Studies”) focusing on ketamine’s safety, tolerability and effectiveness. “The publications of data as it relates…

FridayJun 19, 2020 9:44 am

QualityStocksNewsBreaks – Trxade Group, Inc. (NASDAQ: MEDS) Announces Details for June 24 Virtual Presentation

Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery, and healthcare platform, on Monday announced that management will deliver a virtual presentation at 11:30 a.m. Eastern Time on Wednesday, June 24, 2020. According to the update, Trxade CEO Suren Ajjarapu will present an overview of the business model and growth initiatives of the company during the webinar, which will be followed with a question and answer session. Interested parties may access the webinar by dialing 1-877-425-9470 or 1-201-389-0878 (International) and entering conference code: 13705066. To register and log into the webcast, visit http://ibn.fm/R50l7 To view the full press release, visit http://ibn.fm/Lby8X…

WednesdayJun 17, 2020 12:46 pm

QualityStocksNewsBreaks – Trxade Group, Inc. (NASDAQ: MEDS) Coverage Initiated by Taglich Brothers

Coverage of Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform, has been initiated by Taglich Brothers, Inc., a full-service broker dealer focused exclusively on microcap companies. Taglich Brothers offers institutional and retail brokerage services, investment banking and comprehensive research coverage to the investment community. To request access to the complete 20-page report on Trxade Group, visit www.TaglichBrothers.com. To view the full press release, visit http://ibn.fm/Fx7k1 About Trxade Group, Inc. Headquartered in Tampa, Florida, Trxade Group, Inc. (NASDAQ: MEDS) is an integrated drug procurement, delivery and healthcare platform that fosters price transparency, thereby improving profit margins for…

Site Search

Company Search

Tag: Trxade Group Inc. MEDS